BE904863A - Systeme d'application endonasal. - Google Patents

Systeme d'application endonasal.

Info

Publication number
BE904863A
BE904863A BE1/011501A BE1011501A BE904863A BE 904863 A BE904863 A BE 904863A BE 1/011501 A BE1/011501 A BE 1/011501A BE 1011501 A BE1011501 A BE 1011501A BE 904863 A BE904863 A BE 904863A
Authority
BE
Belgium
Prior art keywords
application system
endonasal application
endonasal
hydroxypropylmethylcellulose
gelatin
Prior art date
Application number
BE1/011501A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE904863A publication Critical patent/BE904863A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Système d'application endonasal solide et poreux comprenant de la gélatine et/ou de l'hydroxypropylméthylcellulose et contenant un médicament actif par voie systémique dispersé à l'intérieur de ce système.
BE1/011501A 1985-06-04 1986-06-03 Systeme d'application endonasal. BE904863A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds

Publications (1)

Publication Number Publication Date
BE904863A true BE904863A (fr) 1986-12-03

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011501A BE904863A (fr) 1985-06-04 1986-06-03 Systeme d'application endonasal.

Country Status (21)

Country Link
US (1) US4988512A (fr)
JP (1) JPS61282320A (fr)
KR (1) KR870000066A (fr)
AU (1) AU5824786A (fr)
BE (1) BE904863A (fr)
CH (1) CH668913A5 (fr)
DE (1) DE3617728A1 (fr)
DK (1) DK259186A (fr)
ES (1) ES8801130A1 (fr)
FR (1) FR2582511B1 (fr)
GB (3) GB8514090D0 (fr)
GR (1) GR861422B (fr)
HU (1) HU199300B (fr)
IL (1) IL78980A0 (fr)
IT (1) IT1214683B (fr)
LU (1) LU86457A1 (fr)
NL (1) NL8601285A (fr)
NZ (1) NZ216393A (fr)
PT (1) PT82691B (fr)
SE (1) SE8602530L (fr)
ZA (1) ZA864164B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
ES2108122T3 (es) * 1991-05-24 1997-12-16 Amylin Pharmaceuticals Inc Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
WO1993013753A1 (fr) * 1992-01-17 1993-07-22 Alfatec-Pharma Gmbh Comprimes contenant des medicaments peptidiques, leur fabrication et leur application
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
EP1061987B1 (fr) * 1998-02-13 2006-05-17 Bioniche Life Sciences Inc. Dispositif servant a administrer un medicament
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
WO2005097210A1 (fr) * 2004-03-26 2005-10-20 The University Of Utah Research Foundation Systeme polymere biosensible pour l'administration de microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (fr) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
HU199300B (en) 1990-02-28
GB2176105A (en) 1986-12-17
DK259186A (da) 1986-12-05
GB2213377A (en) 1989-08-16
IT8648098A0 (it) 1986-06-04
FR2582511A1 (fr) 1986-12-05
IL78980A0 (en) 1986-09-30
GB2176105B (en) 1990-03-07
FR2582511B1 (fr) 1989-05-26
PT82691B (en) 1988-05-03
IT1214683B (it) 1990-01-18
PT82691A (en) 1986-07-01
ES555676A0 (es) 1988-01-01
GR861422B (en) 1986-10-01
GB8906584D0 (en) 1989-05-04
LU86457A1 (fr) 1987-01-13
GB8514090D0 (en) 1985-07-10
KR870000066A (ko) 1987-02-16
SE8602530D0 (sv) 1986-06-04
ZA864164B (en) 1988-01-27
GB8613284D0 (en) 1986-07-09
HUT49288A (en) 1989-09-28
SE8602530L (sv) 1986-12-05
NL8601285A (nl) 1987-01-02
NZ216393A (en) 1989-08-29
CH668913A5 (de) 1989-02-15
AU5824786A (en) 1986-12-11
JPS61282320A (ja) 1986-12-12
US4988512A (en) 1991-01-29
ES8801130A1 (es) 1988-01-01
DK259186D0 (da) 1986-06-02
DE3617728A1 (de) 1986-12-04

Similar Documents

Publication Publication Date Title
DE69512491D1 (de) Aktives Führungssystem eines Aufzuges
DK618186A (da) Konfektureindgiftssystem til aktive stoffer
IT8521922A0 (it) Sistema di somministrazione di farmaci.
NL194604B (nl) Implanteerbaar geneesmiddelpompsysteem.
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
DK453585A (da) Laegemiddel-indgivelsessystem
IT8667657A1 (it) Dispositivo erogatore per la somministrazione di un agente benefico all'ambiente d'uso particolarmente per la somministrazione di un agente terapeutico ad un animale ruminante.
EP0654973A4 (fr) Systeme d'administration d'un medicament aux tissus lyphatiques.
ATE282600T1 (de) Salpetersäuresalze von antihypertensiven arzneimitteln
DK175487D0 (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
IT8520973A0 (it) Benzoil-uree ad attivita'insetticida.
AU8439998A (en) Compounds
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
FR2582511B1 (fr) Systeme d'application endonasal
IT1206452B (it) Ammidine ad attivita' farmaceutica e relativo procedimento di fabbricazione.
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
IT1208512B (it) Benzoil-uree ad attivita'insetticida.
EP0638080A4 (fr) PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], UTILISATION PHARMACEUTIQUE ET COMPOSITIONS CONTENANT LADITE PYRIMIDINE.
IT1284764B1 (it) Batteria di gabbie per avicoltura.
ATE131047T1 (de) Osteogenesis-stimulierende mittel.
IT8621557A0 (it) Antibiotici peptidici ad attivita'antimicrobica ed antitumorale.
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
IT8619162A0 (it) Composti acilamminoalcanoilici adattivita' farmaceutica.
ATE57526T1 (de) P-acylaminobenzamide.
FR2751967B1 (fr) Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19950630